This past year was not a good one for the Spanish pharmaceutical sector. According to a calculation, the six listed companies on the continuous market has...
Devicare had a turnover of one million euros in the 2020 financial year and expects to grow by 50% this year. Since its founding, the Spanish...
With the first part of their project completed and the good results endorsing Ikan Biotech, the next step that both Rubén and Roberto considered was to...
Time is Brain has raised $976,000 (€800,000) during the last financing round, which means it surpassed the initial target, set at more than $855,000 (€700,000). Ayce...
The company Seagen, which works with improved antibodies that make the drugs more potent, has revenues of $1.5 billion. The biotech company is working with Esteve...
The serological method, called Scovam is a fluorescence-based assay that allows simultaneous detection of IgM and IgG antibodies in a microdrop of blood serum. According to...
In February 2021, Rovi announced that it expected operating income for the current fiscal year to increase by 20% to 30%, including the production of Moderna's...
The Spanish biotech company Prim has recently published its first quarter financial results. The company has reduced its revenues by 3.1%, to $45 million (€37.2 million)....
Berdac has just closed a financing round led by Big Sur Ventures. The company plans to distribute 5,000 units in Spain in 2021 and is negotiating...
A spin-off of the Hospital Clínica de Barcelona, the University of Navarra, and the University of San Buenaventura de Cali, the company has so far received...